Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.

Recent & Breaking News (GREY:IMVIQ)

IMV to Present at BTIG's Virtual Biotechnology Conference

Business Wire July 29, 2020

IMV Announces Appointment of Michael P. Bailey to Board of Directors

Business Wire July 20, 2020

IMV Updates Rapid Progress on COVID-19 Vaccine Program

Business Wire July 14, 2020

IMV maintains the remainder of its At-the-Market Facility under its new Base Shelf Prospectus

Business Wire June 30, 2020

IMV Announces Annual and Special Meeting of Shareholders Voting Results

Business Wire June 29, 2020

IMV Files Preliminary Base Shelf Prospectus to Replace Expiring Base Shelf Prospectus

Business Wire June 19, 2020

IMV Announces Leading Independent Proxy Advisory Firms Recommend Shareholders Vote FOR All Resolutions at Upcoming Annual and Special Meeting

Business Wire June 15, 2020

IMV to Present at Raymond James' Human Health Innovation Conference

Business Wire June 8, 2020

Clinical Response and Translational Data from DeCidE1, a Phase 2 Study of DPX-Survivac Immunotherapy in Patients with Advanced Recurrent Ovarian Cancer

Business Wire May 29, 2020

IMV Announces Selection of a Vaccine Candidate Against COVID-19 to Advance Into Human Clinical Studies

Business Wire May 21, 2020

IMV Inc. Provides Clinical and Operational Update and Announces First Quarter 2020 Financial Results

Business Wire May 15, 2020

IMV Inc. Announces Closing of $25.1 Million Private Placement

Business Wire May 7, 2020

IMV Inc. to Announce First Quarter 2020 Results and Host a Conference Call and Webcast on May 15, 2020

Business Wire May 4, 2020

Vaccine Candidate to Prevent COVID-19: Fonds de solidarité FTQ to Invest $7.5 Million in IMV

Canada NewsWire April 30, 2020

IMV Announces Proposed $22.3 Million Private Placement

Business Wire April 30, 2020

IMV to Participate in Adelaide Capital's Virtual COVID & Healthcare Mini Conference

Business Wire April 21, 2020

IMV Inc. Announces Fourth Quarter and Full Year 2019 Financial and Operational Results

Business Wire March 30, 2020

IMV Inc. Provides Updates on the Development of DPX-COVID-19 Vaccine and Ongoing Business and Clinical Operations

Business Wire March 30, 2020

IMV to Announce Fourth Quarter and Full Year 2019 Financial and Operational Results and Host Investor Conference Call and Webcast on March 31, 2020

Business Wire March 25, 2020

IMV Inc. Establishes At-the-Market Facility

Business Wire March 18, 2020